IDH3A Antibodies

Santa Cruz Biotechnology features a diverse variety of IDH3A monoclonal antibodies for various research applications. IDH3A monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). IDH3A, part of the isocitrate dehydrogenase family, plays a crucial role in the tricarboxylic acid (TCA) cycle, facilitating the conversion of isocitrate to alpha-ketoglutarate while producing NADH. This metabolic function is essential for cellular energy production and biosynthesis, making IDH3A a significant player in cellular metabolism and overall cellular health. Dysregulation of IDH3A has been implicated in various metabolic disorders and cancers, highlighting its importance in both basic and translational research. Researchers worldwide utilize IDH3A monoclonal antibodies to investigate metabolic pathways, disease mechanisms, and potential therapeutic targets. Understanding IDH3A's role in cellular processes continues to advance scientific knowledge of metabolic regulation and disease development. Santa Cruz Biotechnology monoclonal antibodies enable researchers to make meaningful contributions to metabolic research and therapeutic development.